CHD9 Polyclonal Antibody

Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis.,PTM:Phosphorylated on serine and tyrosine residues.,sequence Wrong choice of frame.,Belongs to the SNF2/RAD54 helicase family.,Contains 1 helicase ATP-binding domain.,Contains 1 helicase C-terminal domain.,Contains 2 chromo domains.,subunit:Interacts with PPARA. Probably interacts with ESR1 and NR1I3.,tissue specificity:Widely expressed at low levels. In bone marrow, expression is restricted to osteoprogenitor cells adjacent to mature osteoblasts.,

The CHD9 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CHD9 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional sensitivity and specificity.

The CHD9 Polyclonal Antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the CHD9 protein. This ensures the generation of a high-affinity antibody that recognizes the target protein with utmost precision. The antibody has been extensively validated through various experimental approaches, including Western blotting, immunohistochemistry, and immunofluorescence, to ensure its reliability and accuracy.

With its exceptional performance, the CHD9 Polyclonal Antibody is an invaluable tool for researchers studying the role of CHD9 in various biological processes. It enables the investigation of CHD9 protein expression patterns in different tissues and cell types, facilitating a deeper understanding of its function and involvement in cellular mechanisms.

The CHD9 Polyclonal Antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a ready-to-use format, eliminating the need for time-consuming preparation steps. The antibody is available in different sizes to accommodate various experimental requirements.

In summary, the CHD9 Polyclonal Antibody is a highly reliable and specific tool for the detection and analysis of CHD9 protein expression. Its exceptional sensitivity and specificity, along with its ease of use, make it an indispensable asset for researchers in the field.